Boston Scientific Corporation (NYSE: BSX) has launched its Coyote™ Balloon Catheter, a highly deliverable and ultra-low profile 0.014 inch balloon dilatation catheter designed to treat patients undergoing peripheral angioplasty procedures below the knee. The Company has begun marketing the product in the U.S., Europe and other international markets.
Boston Scientific developed the Coyote Balloon Catheter to help physicians better treat patients with challenging obstructive lesions in the lower extremities. It features an ultra-low lesion entry profile (0.017 inch), excellent crossing profile and a shaft optimized for outstanding deliverability. The balloon offers rapid deflation times and is available in lengths up to 220 mm on both Over-the-Wire (OTW) and Monorail® platforms.
“The Coyote Balloon Catheter’s low profile and ability to navigate through challenging vasculature make it ideal for treating vessels in the lower extremities,” said J. A. Mustapha, M.D., Director of Endovascular Intervention at Metro Health Hospital in Wyoming, MI. “Its performance gives me greater confidence in being able to effectively treat patients with difficult anatomy who suffer from peripheral artery disease.”
“With an ultra-low profile and extended balloon lengths on a variety of catheter platforms, the Coyote Balloon Catheter is designed specifically for interventionalists treating patients with demanding peripheral lesions below the knee,” said Jeff Mirviss, President of Boston Scientific’s Peripheral Interventions Division. “It builds on Boston Scientific’s global leadership in low-profile peripheral balloon angioplasty and reflects our commitment to meeting physician and patient needs through innovative medical technology.”
Coyote is the latest in a series of innovative balloon catheter products introduced by Boston Scientific. In June, the Company launched its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures.
An estimated 8 to 10 million patients in the United States alone suffer from peripheral artery disease (PAD), which is characterized by blockages in vessels of the peripheral vasculature and associated with high rates of morbidity. Balloon catheters are used in peripheral angioplasty and stenting procedures to open blocked arteries.
Source: Boston Scientific
published: October 4, 2011 in: Boston Scientific, Launches / Withdrawals, Vascular